Molecular determinants of sensitivity to antitumor agents.
Kastan
M B
MB
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. Michael.Kastan@stjude.org
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D004260:DNA Repair; D016503:Drug Delivery Systems; D015195:Drug Design; D004351:Drug Resistance; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D026901:Membrane Transport Proteins; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000378:metabolism*
D000970:Antineoplastic Agents; D002352:Carrier Proteins; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; C120043:SLC19A2 protein, human